Edwards Lifesciences Corp (EW)
Days of sales outstanding (DSO)
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Receivables turnover | — | — | — | — | — | |
DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days of sales outstanding (DSO) ratio for Edwards Lifesciences Corp has been consistently reported as not available (\u2014 days) for the years 2020, 2021, 2022, 2023, and 2024. Without specific DSO values, it is challenging to assess the efficiency of the company in collecting its accounts receivable and managing its sales cycle. Further insights or contextual information would be necessary to provide a more in-depth analysis of Edwards Lifesciences Corp's liquidity and operational performance.
Peer comparison
Dec 31, 2024
Company name
Symbol
DSO
Edwards Lifesciences Corp
EW
—
Align Technology Inc
ALGN
—
Avanos Medical Inc
AVNS
—
Intuitive Surgical Inc
ISRG
49.91
MSA Safety
MSA
—
STERIS plc
STE
71.62
Zimmer Biomet Holdings Inc
ZBH
72.70
See also:
Edwards Lifesciences Corp Average Receivable Collection Period